Skip to content
Teethgrinder – Lifestyle
Author:
SystImmune, Inc.
SystImmune Reports Phase 1 Data for BL-M14D1 Demonstrating Promising Activity in Small-Cell Lung Cancer at ASCO
June 1, 2026